(NASDAQ: TIL) Instil Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.72%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.31%.
Instil Bio's earnings in 2024 is -$75,165,000.On average, 2 Wall Street analysts forecast TIL's earnings for 2024 to be -$69,239,661, with the lowest TIL earnings forecast at -$86,272,226, and the highest TIL earnings forecast at -$52,207,096. On average, 2 Wall Street analysts forecast TIL's earnings for 2025 to be -$55,339,522, with the lowest TIL earnings forecast at -$101,738,578, and the highest TIL earnings forecast at -$8,940,465.
In 2026, TIL is forecast to generate -$4,502,862 in earnings, with the lowest earnings forecast at -$4,502,862 and the highest earnings forecast at -$4,502,862.